What's driving IGC's earnings surprises recently?

IGC Pharma, Inc. has not reported any earnings surprises recently. The most recent earnings report was for the third fiscal quarter of 2025, ended December 31, 2024. IGC has been actively expanding its clinical trials, including the addition of a prestigious research site at Butler Hospital’s Memory and Aging Program, which could be contributing to the expenses of the company. Furthermore, the company has been advancing its investigational drug assets targeting Alzheimer's disease, which may be impacting the results of the company's clinical trials.